Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models

Juvenile Idiopathic Arthritis

Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis: part 1-results of the Canadian model in the Nordic cohort

Arthritis Res Ther.

Rypdal V, Guzman J, Henrey A, Loughin T, Glerup M, Arnstad ED, Aalto K, Rygg M, Nielsen S, Herlin T, Fasth A, Berntson L, Rypdal M, Nordal E, ReACCh-Out and NoSPeR Investigators.

doi: 10.1186/s13075-019-2060-2.

Juvenile Idiopathic Arthritis

Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials

Ann Rheum Dis.

Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat NM, Horneff G, Kasapcopur O, Schneider R, Anton J, Barash J, Berner R, Corona F, Cuttica R, Fouillet-Desjonqueres M, Fischbach M, Foster HE, Foell D, Radominski SC, Ramanan AV, Trauzeddel R, Unsal E, Levy J, Vritzali E, Martini A, Lovell DJ

doi: 10.1136/annrheumdis-2018-213150.

Juvenile Idiopathic Arthritis

Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort

Arthritis Res Ther.

Henrey A, Rypdal V, Rypdal M, Loughin T, Nordal E, Guzman J, ReACCh-Out and NoSPeR Investigators.

doi: 10.1186/s13075-019-2091-8.

Predictors of changes in disease activity among children with juvenile dermatomyositis enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry

Clin Rheumatol.

Challa D, Crowson CS, Niewold TB, Reed AM; CARRA Legacy Registry Investigators

doi: 10.1007/s10067-017-3901-5.

Rheumatoid Arthritis

Latent class trajectory modelling of 2-components-DAS28 identifies multiple rheumatoid arthritis phenotypes of response to biologic disease modifying anti-rheumatic drugs

Arthritis Rheumatol.

Dagliati A, Plant D, Nair N, Jani M, Amico B, Peek N, Morgan AW, Isaacs J, Wilson AG, Hyrich KL, Geifman N, Barton A, BRAGGSS.

doi: 10.1002/art.41379.

Rheumatoid Arthritis

Early response to anti-TNF predicts long-term outcomes including sustained remission: an analysis of the BSRBR-RA

Rheumatology (Oxford).

Hamann PDH, Pauling JD, McHugh N, Hyrich K, Shaddick G

doi: 10.1093/rheumatology/kez518.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster

Clin Immunol.

Han Y, Jiang M, Xia D, He L, Lv X, Liao X, Meng J

doi: 10.1016/j.clim.2020.108413.

Osteoporosis

Performing routine follow-up biopsy 1 year after diagnosis does not affect long-term outcomes in coeliac disease

Aliment Pharmacol Ther.

Pekki H, Kurppa K, Mäki M, Huhtala H, Laurila K, Ilus T, Kaukinen K

doi: 10.1111/apt.14048.

Psoriasis

High prevalence of alcohol use disorders in patients with inflammatory skin diseases

Br J Dermatol.

Al-Jefri K, Newbury-Birch D, Muirhead CR, Gilvarry E, Araújo-Soares V, Reynolds NJ, Kaner E, Hampton PJ

doi: 10.1111/bjd.15497.

Related content

Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis: part 1-results of the Canadian model in the Nordic cohort

Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials

Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort

Predictors of changes in disease activity among children with juvenile dermatomyositis enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry

Latent class trajectory modelling of 2-components-DAS28 identifies multiple rheumatoid arthritis phenotypes of response to biologic disease modifying anti-rheumatic drugs

Early response to anti-TNF predicts long-term outcomes including sustained remission: an analysis of the BSRBR-RA

COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster

Performing routine follow-up biopsy 1 year after diagnosis does not affect long-term outcomes in coeliac disease

High prevalence of alcohol use disorders in patients with inflammatory skin diseases